Pro-inflammatory cytokine signaling and glial activation

Pro-inflammatory cytokine signaling and glial activation refers to the coordinated immune response within the central nervous system (CNS) involving the activation of microglia and astrocytes. In response to pathological triggers such as misfolded protein aggregates (e.g., amyloid-beta or alpha-synuclein) or traumatic injury, these glial cells transition into a reactive state and release a cascade of pro-inflammatory mediators, including TNF-α, IL-1β, and IL-6. While acute activation is a protective mechanism intended to clear debris and pathogens, chronic or dysregulated activation leads to a self-perpetuating cycle of neuroinflammation that drives neuronal dysfunction and death in neurodegenerative diseases like Alzheimer's and Parkinson's. Therapeutic strategies targeting this process aim to dampen the inflammatory response by inhibiting specific cytokine pathways or modulating glial phenotypes from a neurotoxic (M1-like) to a neuroprotective (M2-like) state. However, because these signaling pathways are also essential for normal brain homeostasis and repair, broad inhibition poses significant safety risks, including immunosuppression and impaired synaptic maintenance.

Other names

NeuroinflammationGlial activation pathwayCytokine-mediated neurotoxicityNeuroinflammatory cascade

Inhibition of pro-inflammatory cytokine production or signaling and suppression of microglial and astrocytic activation to reduce neurotoxicity.